ARCHIVES

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

This article is from The Cancer Letter archive.

Vol. 11 No. 10 | March 8, 1985

Download PDF Visit The Full Archive

Related Articles

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

September 15, 2006

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

October 23, 1992

In Brief: ACCC Meeting Move To Jan. 31 In Jacksonville; ACS Gynecologic Cancer Meeting Sept. 18-20 In Phila.

August 22, 1975

Report Finds NIH Not At Fault in Case Of P-32 Ingestion

September 26, 1997